Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Br J Nutr ; 123(10): 1081-1093, 2020 05 28.
Artigo em Inglês | MEDLINE | ID: mdl-32037990

RESUMO

Foamy, whitish appearance of the pyloric caeca, reflecting elevated lipid content, histologically visible as hypervacuolation, is frequently observed in Atlantic salmon fed high-plant diets. Lipid malabsorption syndrome (LMS) is suggested as term for the phenomenon. Earlier studies have shown that insufficient supply of phospholipids may cause similar symptoms. The objective of the present study was to strengthen knowledge on the role of choline, the key component of phosphatidylcholine, in development of LMS as well as finding the dietary required choline level in Atlantic salmon. A regression design was chosen to be able to estimate the dietary requirement level of choline, if found essential for the prevention of LMS. Atlantic salmon (456 g) were fed diets supplemented with 0, 392, 785, 1177, 1569, 1962, 2354, 2746 and 3139 mg/kg choline chloride. Fish fed the lowest-choline diet had pyloric caeca with whitish foamy surface, elevated relative weight, and the enterocytes were hypervacuolated. These characteristics diminished with increasing choline level and levelled off at levels of 2850, 3593 and 2310 mg/kg, respectively. The concomitant alterations in expression of genes related to phosphatidylcholine synthesis, cholesterol biosynthesis, lipid transport and storage confirmed the importance of choline in lipid turnover in the intestine and ability to prevent LMS. Based on the observations of the present study, the lowest level of choline which prevents LMS and intestinal lipid hypervacuolation in post-smolt Atlantic salmon is 3·4 g/kg. However, the optimal level most likely depends on the feed intake and dietary lipid level.


Assuntos
Ração Animal/análise , Colina/administração & dosagem , Gorduras na Dieta/administração & dosagem , Enterócitos/metabolismo , Salmo salar/metabolismo , Animais , Ceco/metabolismo , Suplementos Nutricionais , Metabolismo dos Lipídeos , Lipídeos/análise , Síndromes de Malabsorção/etiologia , Síndromes de Malabsorção/prevenção & controle , Necessidades Nutricionais , Água do Mar
2.
Reproduction ; 133(2): 467-77, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17307914

RESUMO

On the molecular level, essential fatty acid deficiency (EFAD) has been associated with induced fatty acid (FA) desaturase expression and activity in several tissues. However, there seem to be exceptions. In the present study, we examine the effects of EFAD in the male rat genital tract, combining FA analysis, gene expression studies, and morphological evaluation of epididymal spermatozoa. When feeding 21-day-old Wistar rats, a fat-free diet for 6 weeks, an increase in 18:1n-9 and 20:3n-9 and a concomitant decrease in the 18:2n-6 and 20:4n-6 species are seen in testis, as well as in liver. However, with regard to desaturase expression the rat testis seems to be unresponsive to EFAD conditions, in contrast to other organs studied. In the sexually mature testis none of the desaturases (SCD1, SCD2, D5D, or D6D) are induced in response to lowered contents of polyunsaturated FAs. This also applies to caput epididymis, while EFAD sensitivity is regained in cauda epididymis, where the desaturases are upregulated. The FA profile of epididymal spermatozoa is increasingly affected by EFAD during the transport from testis to cauda epididymis. Furthermore, a significant increase in the number of abnormal spermatozoa is observed in cauda epididymis.


Assuntos
Epididimo/enzimologia , Ácidos Graxos Dessaturases/metabolismo , Ácidos Graxos Essenciais/deficiência , Testículo/enzimologia , Animais , Ácido Araquidônico/farmacologia , Cromatografia Gasosa , Dieta , Ativação Enzimática , Epididimo/química , Ácidos Graxos Dessaturases/genética , Ácidos Graxos Essenciais/análise , Ácidos Graxos Essenciais/metabolismo , Metabolismo dos Lipídeos , Lipídeos/química , Fígado/química , Fígado/metabolismo , Masculino , RNA Mensageiro/análise , Ratos , Ratos Wistar , Células de Sertoli/enzimologia , Espermatozoides/química , Espermatozoides/citologia , Espermatozoides/metabolismo , Estearoil-CoA Dessaturase/genética , Estearoil-CoA Dessaturase/metabolismo
3.
Tidsskr Nor Laegeforen ; 122(17): 1686-7, 2002 Jun 30.
Artigo em Norueguês | MEDLINE | ID: mdl-12555613

RESUMO

Axel Holst (1860-1931), professor of hygiene and bacteriology at the University of Oslo and paediatrician Theodor Frølich (1870-1947) became interested in a disease termed "ship beriberi" which afflicted the crews of sailing ships, and which showed an uncanny likeness to scurvy. They suspected a nutritional deficiency, and established an animal model that allowed systematic study of factors that led to disease as well as the preventive value of different substances. The choice of the guinea pig as the experimental animal for these studies was one indeed fortuitous, as that species has been shown to be among the very few mammals incapable of endogenous synthesis of ascorbic acid. They found that the guinea pigs developed distinctly scurvy-like symptoms when fed a diet consisting of various types of grain either whole or baked into bread, and that these symptoms were prevented when the diet was supplemented with known antiscorbutics like fresh cabbage or lemon juice. Their findings were published in 1907 in the Journal of Hygiene, but caused scientific uproar since the concept of nutritional deficiencies was a novelty at the time. The crucial factor, Vitamin C, was discovered in 1930 by Albert Szent-Györgyi, for which he was rewarded the Nobel Prize. No prizes or proper recognition were awarded Holst and Frølich at the time. It took some 60 years before they due acclaim was given to them; the 1907 paper by Holst and Frølich is now considered the most important single contribution to elucidating the aetiology of scurvy.


Assuntos
Distúrbios Nutricionais/história , Escorbuto/história , Animais , Deficiência de Ácido Ascórbico/história , Cobaias , História do Século XIX , História do Século XX , Humanos , Higiene/história , Medicina Naval/história , Distúrbios Nutricionais/prevenção & controle , Escorbuto/etiologia , Escorbuto/prevenção & controle , Navios/história
4.
J Biol Chem ; 278(33): 30525-33, 2003 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-12756242

RESUMO

Lowering of plasma triglyceride levels by hypolipidemic agents is caused by a shift in the liver cellular metabolism, which become poised toward peroxisome proliferator-activated receptor (PPAR) alpha-regulated fatty acid catabolism in mitochondria. After dietary treatment of rats with the hypolipidemic, modified fatty acid, tetradecylthioacetic acid (TTA), the energy state parameters of the liver were altered at the tissue, cell, and mitochondrial levels. Thus, the hepatic phosphate potential, energy charge, and respiratory control coefficients were lowered, whereas rates of oxygen uptake, oxidation of pyridine nucleotide redox pairs, beta-oxidation, and ketogenesis were elevated. Moderate uncoupling of mitochondria from TTA-treated rats was confirmed, as the proton electrochemical potential (Delta(p)) was 15% lower than controls. The change affected the Delta(Psi) component only, leaving the (Delta)pH component unaltered, suggesting that TTA causes induction of electrogenic ion transport rather than electrophoretic fatty acid activity. TTA treatment induced expression of hepatic uncoupling protein 2 (UCP-2) in rats as well as in wild type and PPARalpha-deficient mice, accompanied by a decreased double bond index of the mitochondrial membrane lipids. However, changes of mitochondrial fatty acid composition did not seem to be related to the effects on mitochondrial energy conductance. As TTA activates PPARdelta, we discuss how this subtype might compensate for deficiency of PPARalpha. The overall changes recorded were moderate, making it likely that liver metabolism can maintain its function within the confines of its physiological regulatory framework where challenged by a hypolipemic agent such as TTA, as well as others.


Assuntos
Metabolismo Energético/fisiologia , Hepatócitos/metabolismo , Proteínas de Membrana Transportadoras , Mitocôndrias Hepáticas/metabolismo , Proteínas Mitocondriais , Proteínas/genética , Proteínas/metabolismo , Animais , Antioxidantes/farmacologia , Gorduras na Dieta/farmacocinética , Eletroquímica , Ácidos Graxos/farmacocinética , Expressão Gênica/efeitos dos fármacos , Canais Iônicos , Masculino , Camundongos , Camundongos Mutantes , Mitocôndrias Hepáticas/química , Oxirredução , Ratos , Ratos Wistar , Receptores Citoplasmáticos e Nucleares/genética , Receptores Citoplasmáticos e Nucleares/metabolismo , Sulfetos/farmacologia , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Proteína Desacopladora 2
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa